TrialPloS one2018

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.

Wenbo Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.